Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy

Ozturk H., ORAY M., Tugal-Tutkun I.

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.26, sa.7, ss.1005-1014, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 7
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1080/09273948.2017.1355471
  • Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1005-1014
  • Anahtar Kelimeler: Behcet uveitis, central macular thickness, fluorescein angiography score, laser flare, tocilizumab, REFRACTORY UVEITIS, DISEASE, INTERLEUKIN-6, MULTICENTER, DIAGNOSIS, ARTHRITIS, FLARE
  • Ondokuz Mayıs Üniversitesi Adresli: Hayır

Özet

Purpose: To report the results of tocilizumab (TCZ) treatment in patients with Behcet uveitis (BU) who had failed conventional, interferon alpha, and anti-Tumor necrosis factor-alpha therapy.